Evidence map›Paper›PMID 40722452›Full record

ReviewBioengineering (Basel, Switzerland)2025

Mechanotransduction: A Master Regulator of Alveolar Cell Fate Determination.

Kusum Devi, Kalpaj R Parekh

Abstract readReview
In one paragraph

Review in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kusum DeviDepartment of Cardiothoracic Surgery, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Kalpaj R ParekhDepartment of Cardiothoracic Surgery, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

Funding

Pathogenesis of Airway Stem Cell Abnormalities in Obliterative BronchiolitisR01HL136370 · NHLBI · UNIVERSITY OF IOWA · PI Kalpaj Rajnikant Parekh, Wa Xian · 2019 to 2026
$4.2M
National Institute of Health/NHLBI 2R01HL136370-06 (P.I. Kalpaj R. Parekh)NHLBI NIH HHS R01 HL136370
6 · The paper itself

Abstract

Mechanotransduction plays an essential role in the fate determination of alveolar cells within the pulmonary system by translating mechanical forces into intricate biochemical signals. This process exclusively governs differentiation, phenotypic stability, and maintenance of alveolar epithelial cell subtypes, primarily the alveolar AT1/AT2 cells. Perturbed mechanical tension proportionally impacts alveolar cell phenotypic identity and their functional characteristics. The fundamental influence of respiratory mechanics on alveolar cell lineage commitment and sustenance is undeniable. AT1 cells are recognized as principal mechanosensors within the alveolus, directly perceiving and responding to mechanical forces imposed by respiration through cell-matrix interactions. These mechanical forces instigate a profound reorganization of the actin cytoskeleton within cells, indispensable for signal transduction and perpetuation of their differentiated phenotype, orchestrated by integrins and cell adhesion molecule-mediated signaling. The dysregulated mechanotransduction in the pulmonary system intrinsically contributes to the etiology and progression of various diseases, exemplified by pulmonary fibrosis. This review systematically elucidates the profound impact of mechanotransduction on alveolar cell differentiation and fate sustenance and underscores how its dysregulation contributes to the initiation and perpetuation of lung diseases.

Indexed as

AT-AT2 differentiationcell fate maintenancemechanotransductionmechanotransduction-mediated signaling

Identifiers

PMID40722452
PMCPMC12292443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.